BACKGROUND: Carriers of fragile X mental retardation 1 (FMR1) repeat expansions in the premutation range (55-200 CGG repeats) often develop a syndrome of kinetic tremor, cerebellar ataxia, and parkinsonism; designated the fragile X-associated tremor ataxia syndrome (FXTAS). Neurological signs have not been reported in carriers of gray zone (45-54 CGG repeats) expansions. METHODS/ RESULTS: We describe 3 patients with FMR1 gray zone alleles who meet diagnostic criteria for FXTAS. CONCLUSIONS: Our cases suggest that the definition of the FXTAS may need to be broadened to include individuals with FMR1 repeat expansions in the gray zone. These neurological signs may be due to elevated levels of expanded CGG repeat FMR1 mRNA in the gray zone carriers, similar to the changes seen in premutation carriers with FXTAS.
BACKGROUND: Carriers of fragile X mental retardation 1 (FMR1) repeat expansions in the premutation range (55-200 CGG repeats) often develop a syndrome of kinetic tremor, cerebellar ataxia, and parkinsonism; designated the fragile X-associated tremor ataxia syndrome (FXTAS). Neurological signs have not been reported in carriers of gray zone (45-54 CGG repeats) expansions. METHODS/ RESULTS: We describe 3 patients with FMR1 gray zone alleles who meet diagnostic criteria for FXTAS. CONCLUSIONS: Our cases suggest that the definition of the FXTAS may need to be broadened to include individuals with FMR1 repeat expansions in the gray zone. These neurological signs may be due to elevated levels of expanded CGG repeat FMR1 mRNA in the gray zone carriers, similar to the changes seen in premutation carriers with FXTAS.
Authors: S Ennis; A Murray; S Youings; G Brightwell; D Herrick; S Ring; M Pembrey; N E Morton; P A Jacobs Journal: Ann Hum Genet Date: 2006-03 Impact factor: 1.670
Authors: Michael R Hunsaker; Claudia M Greco; Flora Tassone; Robert F Berman; Rob Willemsen; Randi J Hagerman; Paul J Hagerman Journal: J Neuropathol Exp Neurol Date: 2011-06 Impact factor: 3.685
Authors: Danuta Z Loesch; Quang M Bui; Richard M Huggins; Robert J Mitchell; Randi J Hagerman; Flora Tassone Journal: J Med Genet Date: 2006-08-11 Impact factor: 6.318
Authors: D Z Loesch; M S Khaniani; H R Slater; J P Rubio; Q M Bui; K Kotschet; W D'Souza; A Venn; P Kalitsis; A K H Choo; T Burgess; L Johnson; A Evans; M Horne Journal: Clin Genet Date: 2009-09-30 Impact factor: 4.438
Authors: A Maddalena; C S Richards; M J McGinniss; A Brothman; R J Desnick; R E Grier; B Hirsch; P Jacky; G A McDowell; B Popovich; M Watson; D J Wolff Journal: Genet Med Date: 2001 May-Jun Impact factor: 8.822
Authors: L Santa María; A Pugin; M A Alliende; S Aliaga; B Curotto; T Aravena; H-T Tang; G Mendoza-Morales; R Hagerman; F Tassone Journal: Clin Genet Date: 2013-10-13 Impact factor: 4.438
Authors: Marsha Mailick; Jinkuk Hong; Jan Greenberg; Leann Smith Dawalt; Mei Wang Baker; Paul J Rathouz Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2017-04-13 Impact factor: 3.568